A detailed history of Captrust Financial Advisors transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Captrust Financial Advisors holds 4,965 shares of JAZZ stock, worth $608,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,965
Previous 4,535 9.48%
Holding current value
$608,907
Previous $484,000 14.26%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $43,245 - $50,039
430 Added 9.48%
4,965 $553,000
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $26,816 - $30,696
-258 Reduced 5.38%
4,535 $484,000
Q1 2024

May 15, 2024

SELL
$115.19 - $132.77 $60,129 - $69,305
-522 Reduced 9.82%
4,793 $577,000
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $18,053 - $21,488
-158 Reduced 2.89%
5,315 $653,000
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $888,282 - $1.06 Million
-7,281 Reduced 57.09%
5,473 $708,000
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $958,562 - $1.15 Million
7,825 Added 158.75%
12,754 $1.58 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $23,982 - $28,724
179 Added 3.77%
4,929 $721,000
Q4 2022

Feb 15, 2023

SELL
$129.72 - $159.85 $20,236 - $24,936
-156 Reduced 3.18%
4,750 $756,000
Q3 2022

Nov 16, 2022

BUY
$126.59 - $161.18 $149,376 - $190,192
1,180 Added 31.67%
4,906 $654,000
Q2 2022

Aug 23, 2022

SELL
$141.59 - $168.66 $165,943 - $197,669
-1,172 Reduced 23.93%
3,726 $581,000
Q2 2022

Aug 16, 2022

BUY
$141.59 - $168.66 $168,633 - $200,874
1,191 Added 32.13%
4,898 $764,000
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $11,149 - $13,820
86 Added 2.38%
3,707 $577,000
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $28,768 - $34,960
240 Added 7.1%
3,621 $461,000
Q3 2021

Nov 16, 2021

SELL
$128.64 - $184.79 $13,764 - $19,772
-107 Reduced 3.07%
3,381 $440,000
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $40,050 - $46,605
250 Added 7.72%
3,488 $620,000
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $62,779 - $72,523
418 Added 14.82%
3,238 $532,000
Q4 2020

Feb 16, 2021

BUY
$140.71 - $165.05 $15,478 - $18,155
110 Added 4.06%
2,820 $465,000
Q2 2020

Aug 14, 2020

SELL
$95.68 - $121.88 $57,886 - $73,737
-605 Reduced 18.25%
2,710 $297,000
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $46,063 - $80,188
-525 Reduced 13.67%
3,315 $317,000
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $425,893 - $556,502
3,620 Added 1645.45%
3,840 $570,000
Q2 2019

Aug 13, 2019

BUY
$125.55 - $144.48 $15,066 - $17,337
120 Added 120.0%
220 $31,000
Q1 2019

May 15, 2019

SELL
$121.81 - $142.95 $1,705 - $2,001
-14 Reduced 12.28%
100 $14,000
Q4 2018

Feb 13, 2019

BUY
$115.94 - $166.74 $1,623 - $2,334
14 Added 14.0%
114 $14,000
Q3 2018

Nov 15, 2018

BUY
$161.01 - $180.57 $16,101 - $18,057
100 New
100 $17,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.69B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.